SELP and breast carcinoma: Favored by the interaction between CD44 receptors on BC cells and P-selectin on nanoplatelets, these PLGA nanoparticles could easily accumulate in MDA-MB231 breast cancer cells and exhibited a strong capacity to inhibit breast cancer metastasis in vivo (Ye et al., 2019).